logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5476.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5476.produseast1
Sudan/Chad Disaster | Collections | MSF Science Portal
Sudan/Chad Disaster

Sudan/Chad Disaster

Collection Content

Journal Article
|
Commentary

Implementation of community-based management of severe acute malnutrition in conflict affected regions: a case of South Kordofan, Sudan

Sserwanja Q, Adam OO, Mohamed EH, Adam MB, Mutisya LM
2023-03-29 • Archives of Public Health
2023-03-29 • Archives of Public Health
Malnutrition is the major cause of mortality and morbidity globally with undernutrition contributing about 45% of all deaths of under five children. Besides the direct effects of protrac...
Conference Material
|
Abstract

Incidence of malaria, with or without seasonal malaria chemoprevention (SMC) in Moïssala, Chad 2014-2021

Hilario JS, Calmejane A
2022-06-01 • Epicentre Scientific Day Paris 2022
2022-06-01 • Epicentre Scientific Day Paris 2022
CONTEXT
SMC has been implemented in Moïssala District southern Chad since 2013 by MSF in collaboration with the national and local health authorities to prevent malaria in young chil...
Conference Material
|
Abstract

Innovative interventions for learning and development: improving psychiatric care through remote training and supervision

Nasser H, Jha Y, Keane G, Carreño C, Mental Health Working Group
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
In December 2019, following a request from MSF’s intersectional working group for mental health and psychosocial services, MSF’s telemedicine (TM) services team implemen...

See more collections

TB Research Dissemination Workshop 2022
TB Research Dissemination Workshop 2022

On June 30th-July 1, 2022 the research team at Epicentre in Mbarara, Uganda held a two-day workshop about their recent work to address gaps in tuberculosis diagnostics and therapeutics in low-income countries. Sessions included:


• Landscape of TB disease in Uganda: research gaps

• New diagnostic tools and algorithms in adults

• New diagnostic tools and algorithms in children

• Approaches to increasing pediatric TB detection and reducing disease burden

• TB chemotherapeutics

• Perspectives and challenges in TB


To catch up on the presentations, you can view the abstracts through the link below.

Combatting antibiotic resistance 2022
Combatting antibiotic resistance 2022
Resistance to antibiotics is a growing public health crisis, especially in countries with fragile health systems and in regions at war. The World Health Organization has estimated that antibiotic-resistant bacteria caused nearly 1.3 million deaths in 2019, a toll that will increase significantly in the coming years if effective action is not taken. To mark World Antimicrobial Awareness Week 2022 (18-24 November) we present a snapshot of MSF’s recent work on responding to this growing threat. Since many humanitarian settings lack laboratory capacity to diagnose these infections, MSF and partners have developed two new technologies with the potential to dramatically expand the availability of accurate diagnosis—allowing clinicians to then tailor antibiotic treatment accordingly. Other work from diverse contexts describes practices and challenges related to optimizing rational antibiotic use within health facilities and communities. Lastly, several studies characterize the patterns and prevalence of antibiotic resistance among MSF patients, from hospitalized neonates in Central African Republic to acute trauma patients in Haiti and Yemen.
New tools and approaches to drug-resistant TB
New tools and approaches to drug-resistant TB
The World Health Organization estimates that 410,000 people developed a drug-resistant tuberculosis infection (DR-TB) in 2022, only 40% of whom were diagnosed and started on treatment—and only 63% then cured. Given all these points of failure, innovation in preventing, diagnosing and treating DR-TB cannot come fast enough. To mark World TB Day (24 March 2024) the content collection linked below highlights recent work by MSF and collaborators to help change this grim picture. The TB-PRACTECAL and endTB studies delivered robust evidence for shorter, safer, more effective drug regimens that are already saving lives worldwide. Other studies explore new approaches to preventive treatment and simpler, quicker, accurate detection of TB and drug resistance—especially among difficult-to-diagnose populations such as children and people living with HIV. But to impact DR-TB globally these innovations must become widely accessible. This requires changes on many fronts, as described in an accompanying Collection (Expanding Access to Lifesaving New TB Tools).
View All Collections